Burkitt translocation (8;22)(q24;q11) in a patient with multiple myeloma.
暂无分享,去创建一个
F. Giles | R. Look | R. Schreck | S. W. Lim | G. N. Lawrence | D. Kusuanco | M. Fuerst | S. Lee | C. Kessler
[1] G. I. Obrams,et al. Epidemiology and Biology of Multiple Myeloma , 2012, Springer Berlin Heidelberg.
[2] D. Vesole,et al. Salvage therapy for multiple myeloma: the University of Arkansas experience. , 1994, Mayo Clinic proceedings.
[3] M. Oken. Standard treatment of multiple myeloma. , 1994, Mayo Clinic proceedings.
[4] Francis J. Giles. Multiple myeloma and other differentiated B-cell disorders. , 1994, Current opinion in hematology.
[5] R. Chaganti,et al. Hypermutation of the MYC gene in diffuse large cell lymphomas with translocations involving band 8q24 , 1993, Genes, chromosomes & cancer.
[6] L. Meisner,et al. Use of fluorescence in situ hybridization for retrospective detection of aneuploidy in multiple myeloma , 1993, Genes, chromosomes & cancer.
[7] M. Boccadoro,et al. Role of chemotherapy and GM-CSF on hemopoietic progenitor cell mobilization in multiple myeloma. , 1993, Bone marrow transplantation.
[8] B. Durie. Cellular and molecular genetic features of myeloma and related disorders. , 1992, Hematology/oncology clinics of North America.
[9] R. Kyle,et al. Diagnostic criteria of multiple myeloma. , 1992, Hematology/oncology clinics of North America.
[10] W. Carroll,et al. c-myc hypermutation is ongoing in endemic, but not all Burkitt's lymphoma. , 1991, Blood.
[11] B. Klein,et al. Interleukin-6 is a potent myeloma-cell growth factor in patients with aggressive multiple myeloma. , 1989, Blood.
[12] I. Lisse,et al. Occurrence and type of chromosomal abnormalities in consecutive malignant monoclonal gammopathies: correlation with survival. , 1988, Cancer genetics and cytogenetics.
[13] E. Newcomb,et al. Pathogenesis of Burkitt lymphoma: Expression of an activated c-myc oncogene causes the tumorigenic conversion of EBV-infected human B lymphoblasts , 1987, Cell.
[14] R. Kyle,et al. The clinical significance of cytogenetic studies in 100 patients with multiple myeloma, plasma cell leukemia, or amyloidosis. , 1985, Blood.
[15] S. Raptis,et al. Cytogenetic study in multiple myeloma. , 1984, Cancer genetics and cytogenetics.
[16] R. R. Howe,et al. Distinctive chromosomal abnormalities in histologic subtypes of non-Hodgkin's lymphoma. , 1982, The New England journal of medicine.
[17] N. E. Hansen,et al. Chromosomes and survival in multiple myeloma. A banding study of 25 cases , 1980 .
[18] D. Hossfeld,et al. Karyotype in multiple myeloma and plasma cell leukaemia. , 1993, European journal of cancer.
[19] D. Ledbetter,et al. Alteration and abnormal expression of the c-myc oncogene in human multiple myeloma. , 1988, Blood.
[20] M. Cole. The myc oncogene: its role in transformation and differentiation. , 1986, Annual review of genetics.